Related Experiment Video
Updated: May 5, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Mechanisms of liver injury relevant to pediatric hepatology
1Institute of Child Health, University of Sheffield Children's Hospital, Western Bank, UK.
Insights
Pediatric liver disease stems from hepatocyte injury due to toxins, metabolism errors, viruses, and immune issues. Understanding these causes is key for effective treatment and research into childhood liver conditions.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Cellular Biology
Background:
- Hepatocyte injury is a primary driver of pediatric liver disease.
- Factors influencing hepatocyte injury include liver microenvironment, sepsis, and oxidative stress.
- Diverse etiological factors contribute to liver damage, including toxins, metabolic disorders, viral infections, and immune responses.
Purpose of the Study:
- To review the mechanisms of pediatric liver injury.
- To discuss various causes of liver damage in children, encompassing immune-mediated and genetic disorders.
- To highlight recent advancements in understanding and treating pediatric liver diseases.
Main Methods:
- Literature review of immune mechanisms in liver injury.
- Analysis of monogenic disorders affecting pediatric liver health.
- Discussion of recent findings on mitochondrial disease, NASH, and cholestatic disorders.
Main Results:
- Immune mechanisms contribute to liver injury in conditions like autoimmune hepatitis and viral hepatitis.
- Monogenic disorders such as alpha-1 antitrypsin deficiency and Niemann-Pick C disease exemplify macromolecule retention.
- Tyrosinemia provides a model for understanding biochemical defects, cell injury, and therapeutic interventions.
Conclusions:
- Pediatric liver disease arises from complex interactions influencing hepatocyte injury.
- Understanding specific genetic and immune pathways is crucial for targeted therapies.
- Ongoing research into various liver conditions promises improved outcomes for affected children.
Abstract:
Hepatocyte injury and necrosis from many causes may result in pediatric liver disease. Influenced by other cell types in the liver, by its unique vascular arrangements, by lobular zonation, and by contributory effects of sepsis, reactive oxygen species and disordered hepatic architecture, the hepatocyte is prone to injury from exogenous toxins, from inborn errors of metabolism, from hepatotrophic viruses, and from immune mechanisms. Experimental studies on cultured hepatocytes or animal models must be interpreted with caution. Having discussed general concepts, this review describes immune mechanisms of liver injury, as seen in autoimmune hepatitis, hepatitis B and C infection, the anticonvulsant hypersensitivity syndrome, and autoimmune polyendocrinopathy. Of the monogenic disorders causing significant liver injury in childhood, alpha-1 antitrypsin deficiency and Niemann-Pick C disease demonstrate the effect of endoplasmic or endosomal retention of macromolecules. Tyrosinemia illustrates how understanding the biochemical defect leads to understanding cell injury, extrahepatic porphyric effects, oncogenesis, pharmacological intervention, and possible stem cell therapy. Pathogenesis of cirrhosis in galactosemia remains incompletely understood. In hereditary fructose intolerance, phosphate sequestration causes ATP depletion. Recent information about mitochondrial disease, NASH, disorders of glycosylation, Wilson's disease, and the progressive familial intrahepatic cholestases is discussed.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis II: Pathophysiology

